GILEAD SCIENCES, INC. — Director's Dealing 2016

Sep 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-09-01

Reporting Person: MARTIN JOHN C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-05	Common Stock	J	731917	—	Acquired	731917	Indirect
2016-08-05	Common Stock	G	731917	—	Disposed	3287810	Direct
2016-08-30	Common Stock	G	156714	—	Disposed	3131096	Direct
2016-09-01	Common Stock	M	100000	$16.395	Acquired	3231096	Direct
2016-09-01	Common Stock	S	95600	$77.451	Disposed	3135496	Direct
2016-09-01	Common Stock	S	4400	$78.1926	Disposed	3131096	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-01	Non-qualified Stock Option (Right to Buy)	$16.395	M	100000	Disposed	2017-01-22	Common Stock (100000)	Direct

Footnotes

F1: Shares gifted to family trust.

F2: Shares gifted to charitable trust

F3: Sale prices reported for the transactions reported here range from $77.06 to $78.03. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $78.07 to $78.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.